Evidence map›Paper›PMID 30158665›Full record

ArticleEuropean journal of human genetics : EJHG2019

Y chromosome mosaicism is associated with age-related macular degeneration.

Felix Grassmann, Christina Kiel, Anneke I den Hollander, Daniel E Weeks, Andrew Lotery, Valentina Cipriani, Bernhard H F Weber, International Age-related Macular Degeneration Genomics Consortium (IAMDGC)

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Y Chromosome Loss and Implications for Oncology.Molecular cancer research : MCR · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Felix GrassmannInstitute of Human Genetics, University of Regensburg, Regensburg, Germany.
Christina KielInstitute of Human Genetics, University of Regensburg, Regensburg, Germany.
Anneke I den HollanderDepartment of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
Daniel E WeeksDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Andrew LoteryClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0001-5541-4305
Valentina CiprianiUniversity College London Institute of Ophthalmology, University College London, London, UK.
Bernhard H F WeberInstitute of Human Genetics, University of Regensburg, Regensburg, Germany. bweb@klinik.uni-regensburg.de.ORCID http://orcid.org/0000-0002-8808-7723
International Age-related Macular Degeneration Genomics Consortium (IAMDGC)
University of Regensburg · DEKarolinska Institutet · SERadboud University Nijmegen · NLUniversity College London · GBUniversity of Pittsburgh · USUniversity of Southampton · GB

Funding

International Advancing genomics through the AMD Genomics Consortium (IAMDGC)R01EY022310 · NEI · VANDERBILT UNIVERSITY · PI BLANTON, SUSAN HALLORAN, HAINES, JONATHAN L · 2012 to 2024
$4.9M
NEI NIH HHS R01 EY022310NHLBI NIH HHS HHSN268201200008CNHLBI NIH HHS HHSN268201200008I
6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in industrialised countries, and thereby a major individual but also a socio-economic burden. Y chromosome loss in nucleated blood cells has been implicated in age-related diseases such as Alzheimer disease and was shown to be caused by increasing age, smoking and genetic factors. Mosaic loss of Y chromosome (mLOY) in peripheral blood was estimated from normalised dosages of genotyping chip data covering the male-specific region of the Y chromosome. After quality control, we assessed the association of mLOY on AMD risk in 5772 male cases and 6732 male controls. In controls the prevalence of mLOY increased significantly with age, which is consistent with previous reports. Importantly, mLOY was associated with late-stage AMD with genome-wide significance (OR: 1.332 [95% CI: 1.206; 1.472], P = 1.60e-08), independent of age, the AMD genetic risk score and the first two principle components of ancestry. Additionally conditioning on smoking behaviour had no influence on the observed association strength. mLOY was strongest associated in individuals aged between 65 and 75 years. Taken together, mLOY is significantly associated with risk for AMD, independent of known and potential confounding factors.

Indexed as

MosaicismAgedAged, 80 and overChromosome DeletionChromosomes, Human, YHumansMacular DegenerationMale

Identifiers

PMID30158665
PMCPMC6303255
OpenAlexW2889469195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.